What Is USP/EP Grade Nicotine? Purity Standards Explained

The difference between 95% and 99.5% nicotine purity is not 4.5 percentage points of quality. It is the difference between an industrial feedstock and a pharmaceutical ingredient. If you are putting nicotine into a product that touches a human body, you need to understand what USP/EP grade means and why it matters.

What USP and EP Actually Are

USP stands for United States Pharmacopeia. EP stands for European Pharmacopoeia. Both are official compendia of drug quality standards maintained by independent scientific bodies. The USP is published by the United States Pharmacopeial Convention, a nonprofit organization that has been setting pharmaceutical quality standards since 1820. The EP is maintained by the European Directorate for the Quality of Medicines (EDQM) under the Council of Europe.

When nicotine carries the "USP/EP grade" label, it means the product has been manufactured and tested against the monograph specifications in both references. The nicotine monograph in each pharmacopoeia defines specific identity, purity, and quality parameters that the substance must meet. These specifications were developed based on toxicological data, clinical requirements, and analytical capabilities, not marketing considerations.

These are not marketing terms. They are legally meaningful designations backed by specific, measurable requirements. In the United States, a product labeled USP grade that does not meet the monograph specification is considered adulterated under the Federal Food, Drug, and Cosmetic Act. In Europe, EP compliance carries similar regulatory weight. Misrepresenting compliance is not just bad practice. It carries legal consequences.

The Spec Sheet

USP/EP grade nicotine must hit every one of these marks:

• Nicotine content: 99.0% minimum on a dried basis. The monograph sets the floor. In practice, consistently achieving 99.0% requires manufacturing processes capable of delivering 99.3% or higher, because batch-to-batch variation means targeting the minimum leaves no margin. Well-run facilities routinely deliver 99.5%+ to ensure every batch clears the specification.
• Optical rotation: -166 to -170 degrees. This confirms natural S-(-)-nicotine, not synthetic or racemic material. It is a fingerprint of origin. Synthetic nicotine typically produces racemic mixtures with different optical rotation values, and while synthetic S-nicotine exists, the optical rotation test remains a reliable indicator of extraction source. This parameter also catches degradation, as oxidized nicotine shows altered rotation.
• Heavy metals: Lead, arsenic, cadmium each below 0.5 ppm. Mercury below 0.1 ppm. These limits exist because heavy metals accumulate in the body and have no safe threshold for chronic exposure. The testing is performed using ICP-MS (inductively coupled plasma mass spectrometry), which can detect metals at parts-per-trillion levels. Tobacco plants are known bioaccumulators of heavy metals from soil, making this test particularly important for tobacco-derived nicotine.
• Residual solvents: Compliant with USP <467> / EP 5.4 limits. The extraction and purification of nicotine from tobacco involves solvents, and traces can remain in the finished product. USP <467> classifies solvents into three categories based on toxicity and sets specific limits for each. Common solvents used in nicotine extraction include hexane, ethanol, and various petroleum ethers, each with defined acceptable daily exposure limits.
• Water content: 0.5% maximum by Karl Fischer method. Water content affects both stability and accurate dosing. Excess moisture accelerates nicotine oxidation, leading to color changes and potency loss over time. The Karl Fischer titration method is specified because it measures water specifically, unlike loss-on-drying methods that can be confounded by volatile impurities.
• Appearance: Clear, colorless to pale yellow liquid. Brown or amber means degradation or insufficient purification. Color is actually a surprisingly reliable field indicator of nicotine quality. Freshly distilled, high-purity nicotine is essentially water-white. Any color development indicates either residual impurities from incomplete purification or oxidative degradation from improper handling and storage.
• Microbial limits: Total aerobic count under 100 CFU/g. No E. coli. No Salmonella. These limits reflect the pharmaceutical end-use of the product. While nicotine itself has antimicrobial properties at high concentrations, diluted forms and nicotine salts used in consumer products may not maintain this effect. Starting with low bioburden material is essential.

For a deeper look at how USP and EP standards differ from each other, see our USP vs. EP comparison.

Why the Standards Exist in Two Versions

USP and EP monographs for nicotine overlap substantially but are not identical. The differences reflect different regulatory philosophies and testing traditions between the US and European systems.

The most notable differences are in test methods rather than acceptance criteria. For example, the EP may specify different chromatographic conditions for impurity profiling, or use different reference standards for identification tests. Heavy metals testing methodologies have historically differed, though both pharmacopoeias have converged toward ICP-based methods in recent revisions.

For manufacturers selling into both markets, the practical approach is to test against the stricter of the two requirements for each parameter. This ensures dual compliance without running separate testing programs. Most pure nicotine produced for international markets is tested to meet both monographs simultaneously.

Why Your Customers Can Tell the Difference

For e-liquid manufacturers, impurities are not abstract. They show up as harshness, peppery off-notes, and color drift in finished products. A batch of e-liquid that turns amber on the shelf is not an aging problem. It is a nicotine purity problem. The minor alkaloids present in sub-pharmaceutical-grade nicotine (nornicotine, myosmine, cotinine, and others) oxidize at different rates than nicotine itself, producing colored compounds that darken the liquid over time. Even at concentrations below 1%, these impurities can cause visible color changes within weeks of product manufacture.

Flavor stability is another casualty of impure nicotine. Minor alkaloid impurities interact with flavoring compounds, altering taste profiles in ways that are difficult to predict and impossible to control. E-liquid manufacturers who switch from 97% to 99.5% purity nicotine consistently report that their flavor formulations become more stable and reproducible. The nicotine is no longer a variable in their flavor equation.

For nicotine pouch manufacturers, purity determines delivery consistency. Minor alkaloid contaminants (nornicotine, anabasine, anatabine) alter absorption kinetics through the oral mucosa. These compounds have different pKa values and lipophilicity than nicotine, which means they cross biological membranes at different rates. The result is unpredictable nicotine delivery that varies from batch to batch. Your lab might not catch the variance in chemical testing. Your consumers will notice it as inconsistent satisfaction.

For NRT pharmaceutical companies, the question is simpler. USP/EP compliance is a regulatory requirement. No compliant nicotine, no product approval. The pharmaceutical supply chain has no tolerance for "close enough." Every batch must meet spec, every COA must reference the monograph, and every deviation must be investigated and documented.

How to Verify the Claim

Every batch of pure nicotine should ship with a Certificate of Analysis from an accredited laboratory. The COA should cover every monograph parameter: purity, heavy metals, residual solvents, water content, microbial testing.

There are specific things to look for on a COA that separate genuine documentation from window dressing:

Accreditation marks. The testing laboratory should hold ISO 17025 accreditation with nicotine and related alkaloids in their scope of accreditation. A lab that is ISO 17025 accredited for water testing but not pharmaceutical alkaloid analysis is not providing accredited results for nicotine purity.

Test method references. Each result should cite the specific USP or EP method used. "Purity: 99.5%" without a method reference is not a pharmacopoeial result. It is a number on a page.

Batch-specific data. The COA should reference a specific batch or lot number, manufacturing date, and expiry date. Generic COAs that apply to "all production" are worthless for regulatory purposes and suggest the supplier is not performing batch-level testing.

Related substances profile. Beyond the total purity number, a complete COA includes individual identification and quantification of known impurities. For nicotine, this means reporting levels of nornicotine, anabasine, anatabine, myosmine, and beta-nicotyrine. This impurity profile is often more informative than the headline purity number because it reveals the effectiveness of the purification process.

If a supplier cannot produce a current, batch-specific COA on request, that tells you something. If the COA lacks test method references or accreditation details, that tells you more.

The 95% vs. 99.5% Gap

Nicotine alkaloid at 95% purity contains roughly 5% of other tobacco alkaloids, plant extracts, and processing byproducts. It is amber-brown, has a strong tobacco odor, and is suitable as a feedstock for further refinement. It is not suitable for direct use in consumer products.

That 5% is not inert filler. It is a complex mixture of biologically active compounds. Nornicotine, the most common minor tobacco alkaloid, can form tobacco-specific nitrosamines (TSNAs) under certain conditions. Anabasine and anatabine have their own pharmacological profiles that differ from nicotine. Myosmine is found in other plants besides tobacco and has been studied for its own biological effects. None of these belong in a product where the intended active ingredient is nicotine alone.

At 99.5%, multi-stage distillation has removed virtually everything that is not nicotine. The result is a colorless, nearly odorless liquid. That is the baseline for any product where nicotine contacts a consumer.

The purification process that bridges this gap typically involves multiple distillation stages under reduced pressure (to prevent thermal degradation), followed by additional purification steps such as molecular distillation or selective crystallization of salts. Each stage reduces impurity levels but also reduces yield, which is why pharmaceutical-grade nicotine costs more per kilogram than crude alkaloid extract. The price difference reflects real processing costs, not just a premium for a label.

Storage and Stability

Even USP/EP grade nicotine will degrade if handled improperly. Nicotine is sensitive to three things: oxygen, light, and heat. Exposure to any of these triggers oxidation reactions that produce colored degradation products and reduce potency.

Proper storage means inert atmosphere (nitrogen blanketed), opaque containers, and temperature-controlled environments, typically below 25C for short-term storage and below 5C for long-term. Suppliers who ship nicotine in clear containers or without temperature monitoring during transit are undermining the purity they claim to deliver.

Stability data should be part of the documentation package from your supplier. Accelerated stability studies (40C/75% relative humidity for 6 months) and real-time stability data tell you how long the material maintains spec under defined conditions. Without this data, you are guessing at shelf life, and guessing is not a quality strategy.

Nicotine Salts and Dilutions: How Purity Standards Apply

USP/EP standards apply to freebase nicotine, but the purity of the starting material directly affects derivative products. Nicotine salts (benzoate, bitartrate, salicylate, and others) are synthesized from freebase nicotine, so impurities in the starting material carry through to the salt form. A nicotine benzoate made from 97% freebase nicotine will contain the same impurity profile as its starting material, just at proportionally lower absolute concentrations due to the added mass of the salt-forming acid.

Nicotine dilutions in PG or VG carriers present a similar principle. Diluting impure nicotine does not remove impurities. It dilutes them. For e-liquid manufacturers working with 100mg/mL nicotine bases, starting with USP/EP grade freebase ensures that impurity concentrations in the dilution remain well below levels that affect flavor or stability.

If Someone Offers You "Pharmaceutical Grade" at a Suspiciously Low Price

Ask for the COA and check the numbers. The spec sheet does not lie. Pharmaceutical-grade nicotine requires expensive multi-stage purification, accredited testing, and quality systems that cost real money to maintain. When someone offers USP/EP grade at prices that are 30-40% below market, one of three things is happening: they are selling sub-spec material with a compliant-looking COA, they are cross-subsidizing from another business line (rare and unsustainable), or they are cutting corners on testing and documentation that you will discover only when a regulator or customer audits your supply chain.

The lowest-risk approach is to verify independently. Request a sample, send it to your own accredited lab, and compare the results to the supplier's COA. If the numbers match, you have a qualified supplier. If they do not, you have avoided a problem.

Frequently Asked Questions